COA6 and familial pancreatic carcinoma: These results suggest that COA6 could be a critical regulator of immune suppression in pancreatic cancer, and its role in modulating the immune microenvironment warrants further investigation as a potential therapeutic target to enhance the efficacy of immunotherapy.